N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate

N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate


    • Product Name N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate
    • Alias Boc-Pro-OH
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    176096

    Chemical Formula C12H20N2O5
    Molar Mass 272.298 g/mol
    Appearance Typically a white to off - white solid
    Physical State At Room Temp Solid
    Solubility In Water Low solubility in water
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Melting Point Approximate range: 90 - 95 °C
    Pka Value No specific pKa data readily available for this overall molecule, but the Boc - protected amine may have relevant pKa related to de - protection chemistry
    Stability Stable under normal conditions, but sensitive to strong acids and bases which can lead to Boc - deprotection

    As an accredited N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of N-(Tert - Butoxycarbonyl)Amino]Methyl]Pyrrolidine - 1 - Carboxylate in sealed chemical - grade packaging.
    Shipping "N-(Tert - Butoxycarbonyl)Amino]Methyl]Pyrrolidine - 1 - Carboxylate" is shipped in accordance with chemical safety regulations. It's carefully packaged to prevent leakage, with proper labeling, and transported via approved carriers ensuring secure transit.
    Storage Store “N-(tert -Butoxycarbonyl)amino]methyl]pyrrolidine - 1 - carboxylate” in a cool, dry place, away from direct sunlight and heat sources. Keep it in a well - sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate

    Why Does Thermal Latency in Anhydride-Epoxy Systems Drop Below 40°C with Free Amine Accelerators?

    Formulating single-component adhesives for multilayer ceramic capacitor encapsulation or flip‑chip underfill requires that the curing agent remain dormant at 25 ± 2 °C for a minimum wet‑bench life of 72 h yet initiate rapid network formation when the package reaches a prescribed solder reflow peak of 260 °C. Free amine accelerators—even sterically hindered variants—invariably increase the room‑temperature viscosity drift beyond 30 % within 8 h when evaluated by cone‑and‑plate rheometry at 2 s⁻¹ (ISO 3219:1994). N-(tert‑butoxycarbonyl)aminomethyl]pyrrolidine‑1‑carboxylate circumvents this conflict by presenting a thermally labile carbamate shield over a primary aminomethyl function. During dynamic scanning calorimetry (ASTM E1356‑08, heating rate 10 K/min, nitrogen purge 50 mL/min) the compound exhibits a sharp endothermic deblocking signal with an onset at 121 ± 3 °C and a peak at 134 °C, corresponding to β‑elimination of isobutylene and carbon dioxide. The liberated methylamine‑functionalized pyrrolidine participates as a nucleophilic initiator in the epoxy ring‑opening homopolymerization, and the pyrrolidine‑1‑carboxylic ester moiety remains covalently anchored into the network, contributing to a reduction in equilibrium moisture absorption measured as 1.2 % after 48 h immersion in deionized water at 85 °C (ISO 62:2008). Optimized stoichiometry for a bis‑A epoxy resin with epoxide equivalent weight 186–190 g/eq places the latent hardener loading at 8–12 phr in combination with 0.3 phr acetylacetonate nickel(II) as a dissociation catalyst. At this ratio, pot‑life stability recorded by Ostwald viscometry at 40 °C delivers a viscosity drift below 15 % over 14 days, while the isothermal gel time at 150 °C measured on a heated‑plate gel timer (ASTM D2471‑99) falls consistently between 95 s and 115 s, enabling high‑throughput capillary flow in under‑fill processing. Production‑scale dispensing through a 23‑gauge needle onto FR‑4 substrates pre‑heated to 80 °C achieves void‑free fillets when the thixotropic index—adjusted with 2.5 wt% fumed silica—remains within 3.2–4.0.

    The latency mechanism is severely compromised if residual acidic impurities originating from incomplete Boc‑esterification persist above 0.05 meq/g; such impurities catalyze premature carbamate cleavage and must be reduced by a supplementary wash sequence with 5 % w/w aqueous sodium bicarbonate followed by azeotropic drying with toluene until the Karl‑Fischer water content drops below 150 ppm (ISO 760:1978). At a continuous twin‑screw compounding step (screw diameter 25 mm, L/D 48, zone temperatures 60–85 °C), any residual moisture above this threshold initiates hydrolysis of the pyrrolidine ester bond, leading to a simultaneous release of free acid that protonates the deblocked amine and retards cure. Processors employing this material in a benzoxazine‑epoxy hybrid system for aerospace prepregs additionally report that the onset temperature of deblocking shifts downward by 8–12 °C in matrices containing > 20 wt% bisphenol‑A dicyanate ester, a phenomenon attributed to nucleophilic catalysis by cyanate‑derived imidocarbonate intermediates. In such formulations, the ratio is derated to 5–7 phr and a co‑crosslinker based on 4,4’‑diaminodiphenyl sulfone at 15 phr is introduced to prevent Tg depression below 155 °C as confirmed by thermomechanical analysis (ISO 11359‑2:2021).

    A protective‑group strategy originally developed for solid‑phase peptide synthesis has been adapted to prepare conformationally constrained peptidomimetics where the N‑(tert‑butoxycarbonyl)aminomethyl]pyrrolidine‑1‑carboxylate functions both as an Fmoc‑compatible building block and as a masked lysine surrogate. Loading of the first residue onto a 2‑chlorotrityl chloride resin (loading capacity 0.9 mmol/g) is performed by dissolving 1.5 eq of the carboxylate in anhydrous dichloromethane in the presence of 3.0 eq N,N‑diisopropylethylamine while monitoring resin bead color change from white to pale orange. A Kaiser test conducted after 25 min must return a negative result before the remaining trityl chloride sites are end‑capped with HPLC‑grade methanol containing 2 % v/v DIPEA. Chain elongation proceeds via Fmoc‑deprotection with 20 % piperidine in DMF (two cycles of 5 min + 15 min), followed by activation of the incoming Fmoc‑amino acid with HATU (2.95 eq) and HOAt (3.0 eq) in the presence of 0.4 M collidine. Incorporation of the Boc‑aminomethyl‑pyrrolidine ester at the P2′ position following a difficult β‑branched residue requires double coupling at 40 °C under microwave irradiation at 50 W, with a coupling time extended to 30 min per cycle; incomplete incorporation is flagged by a persistent Fmoc‑dibenzofulvene absorbance at 301 nm exceeding 0.15 AU in the deprotection effluent. After final global deprotection using a cocktail of TFA/TIS/H₂O (95:2.5:2.5 v/v/v, 3 h at 22 °C), the crude peptide is precipitated in chilled diethyl ether (–20 °C), dissolved in 0.1 % aqueous TFA, and purified on a C18 semi‑preparative column (YMC‑Pack ODS‑A, 250 × 20 mm, 5 μm) applying a linear gradient from 5 % to 65 % acetonitrile over 45 min. LC‑MS analysis (ESI+, capillary voltage 3.5 kV) of the target fraction typically yields a monoisotopic mass within 0.15 Da of the theoretical value and a purity exceeding 98.5 area% at 214 nm, meeting the release criterion of ≤ 1.0 % total impurities per ICH Q3A guidelines for drug substance intermediates.

    When Hydrolytic Stability Dictates Phasing of Boc Deprotection in Continuous Flow for API Synthesis

    Manufacturing of small‑molecule drug candidates containing a terminal aminomethylpyrrolidine pharmacophore—such as certain allosteric modulators of the M₄ muscarinic receptor—relies on a convergent assembly where the Boc‑protected fragment is purified, stockpiled, and deblocked immediately before a late‑stage reductive amination or urea formation. The ester moiety in N‑(tert‑butoxycarbonyl)aminomethyl]pyrrolidine‑1‑carboxylate introduces a hydrolysis liability that demands strictly anhydrous deprotection conditions; a screening matrix comparing trifluoroacetic acid/CH₂Cl₂ ratios reveals that the pyrrolidine ester remains 98 % intact when the reaction medium is sparged with dry nitrogen and held at ≤ 5 °C during acid addition, whereas elevating the temperature to 20 °C generates 3–5 area% of the ring‑opened γ‑aminobutyric acid derivative within 40 min (monitored by C8 UPLC at 220 nm, flow rate 0.8 mL/min). Transferring this deprotection to a continuous tubular reactor (ID 1.0 mm, length 15 m, PFA coil) with precise residence time control at 12 min and back‑pressure regulation at 3.5 bar suppresses the side reaction to < 0.8 area%, delivering the free aminomethylpyrrolidine as its trifluoroacetate salt in 95 % yield after in‑line neutralization with a polymer‑supported carbonate cartridge (StratoSpheres™ MP‑CO₃, 2.5 eq relative to TFA). The solution is immediately fed into a subsequent microreactor chip where it reacts with an isocyanate‑functionalized heterocycle; the integrated two‑step sequence maintains a throughput of 1.2 mmol/h and eliminates the need to isolate the hygroscopic amine intermediate. Industrial batches regulated under ICH Q7 require dedicated reactor‑cleaning validation because residual palladium from upstream Sonogashira couplings can de‑block the Boc group at concentrations as low as 50 ppm, causing premature release of free amine and formation of dimeric impurities above the 0.10 % identification threshold.

    Comparative Process Robustness of Boc Deprotection Modes
    ParameterBatch (5 °C)Batch (20 °C)Flow (12 min, 5 °C)
    Ester hydrolysis impurity [%]0.73.80.4
    Residual Boc intermediate [%]0.2< 0.1< 0.05
    Throughput factor1.01.02.2
    Dimer impurity [ppm]42091075
    Equipment turnaround [h]6.56.50.8

    The liberated aminomethylpyrrolidine ester has been exploited as a versatile C‑nucleophile in metal‑catalyzed asymmetric allylic alkylation applied to the kilogram‑scale preparation of a hepatitis C NS3/4A protease inhibitor precursor. Using 1.2 mol% of an [Ir(dbcot)(S)-BINAP]BF₄ catalyst system in THF at 30 °C, the deprotected amine couples with cinnamyl methyl carbonate to install the allyl scaffold with an enantiomeric ratio of 97.5:2.5 as determined by chiral SFC on a Chiralpak AD‑H column (CO₂/MeOH 70:30, 2.5 mL/min, back‑pressure 120 bar). The pyrrolidine‑1‑carboxylate ester remains untouched under these Lewis‑acidic conditions provided the reaction is quenched into aqueous ammonium chloride at pH 7.5 and the organic phase is concentrated at a bath temperature not exceeding 35 °C. Subsequent saponification with lithium hydroxide monohydrate (3.0 eq) in THF/water (3:1 v/v) to furnish the free carboxylic acid for peptide coupling is accomplished with < 0.5 % racemization of the α‑stereocenter when the hydrolysis is ramped from 0 °C to 22 °C over 12 h and the pH is maintained between 11.8 and 12.2 as tracked by an in‑situ Metrohm pH‑stat. Direct coupling of this acid with cyclopropylamine under EDC/HOBt (1.1 eq each) in DMF at 0 °C completes the synthesis of the P1′ fragment, which crystallizes directly from ethyl acetate/heptane (1:4 v/v) with a differential scanning calorimetry melting endotherm onset at 178.6 °C (ASTM E794‑06) and a purity assignable as a primary reference standard suitable for qNMR calibration using maleic acid as internal quantification standard.

    Employing the Boc‑protected scaffold in split‑and‑pool DNA‑encoded library (DEL) synthesis places stringent demands on chemical compatibility with DNA barcodes and the avoidance of cross‑talk during affinity selection. The compound is weighed out in 30 mM stock solutions in acetonitrile‑dimethylacetamide (4:1 v/v) under strict humidity exclusion (< 10 % RH) because the carbamate oxygen is susceptible to exchange with ambient moisture, generating 5–10 ppm free amine per 24 h of bench exposure that leads to high‑background non‑specific binding. Using a standard 96‑well library format, each well receives 50 nmol of a unique headpiece‑linked hexapeptide intermediate anchored through a photocleavable linker; the Boc‑aminomethyl‑pyrrolidine ester is delivered in 100‑fold molar excess relative to the amine loading of the solid support, with activation mediated by a mixture of DPTS (0.5 M) and EDC·HCl (0.2 M) in dry CH₂Cl₂. After 16 h of rotation at 22 °C, LC‑MS analysis of a small cleavage aliquot must confirm complete consumption of the starting headpiece before aqueous work‑up proceeds. The bottleneck encountered during library production is the Boc removal step; standard HCl/dioxane (4 M) compromises DNA integrity with a measurable drop of 20–30 % qPCR amplifiable copy number, whereas milder HCl in cyclopentyl methyl ether (1.5 M) maintains >85 % DNA integrity but prolongs conversion to 4 h. A hybrid protocol using 0.5 M TMSOTf in 2,6‑lutidine/CH₂Cl₂ at –10 °C achieves quantitative deblocking within 25 min while preserving 94 % amplifiable material as verified by quantitative PCR at the Illumina MiSeq adapter region. This data underscores the necessity of matching the Boc deprotection protocol to the exact ester-hybrid architecture; the pyrrolidine carboxylate’s sensitivity to strong protic acids precludes the use of HBr/HOAc cocktails commonly applied to benzyl‑based protection schemes.

    Configuring an Orthogonal Mask for Samarium Diiodide Reductions of Pyrrolidine‑Tethered Weinreb Amides

    Medicinal chemistry routes to constrained γ‑turn mimetics require the suppression of single‑electron reduction of the pyrrolidine ester during SmI₂‑mediated formation of macrocyclic ketones from Weinreb amide precursors. The N‑(tert‑butoxycarbonyl)aminomethyl]pyrrolidine‑1‑carboxylate tolerates the radical conditions provided the reaction is buffered with 4.0 eq of HMPA and the Samarium(II) solution (0.1 M in THF, freshly titrated) is added dropwise at –78 °C over 90 min. Under these conditions, the auxiliary ester remains 95 % intact as assessed by GC‑FID (ZB‑5MSi column, 30 m × 0.25 mm, 0.25 μm) spiked with tetradecane as internal standard. In contrast, identical conditions applied to the corresponding methyl‑ester analogue lead to 28 % over‑reduction to the primary alcohol, a side product that co‑elutes with the desired ketone during flash chromatography on neutral alumina (Brockmann activity II). This selectivity window is essential when the downstream synthetic plan includes a regioselective lactamization between the pyrrolidine carboxylate and a deprotected N‑terminal amine; the isopropyl ester variant has been documented to undergo lactam closure with 5 mol% DMAP in refluxing toluene within 3 h to yield a seven‑membered diazepanone with an isolated yield of 82 % after precipitation from cold diisopropyl ether.

    For manufacturing robustness, the samarium step is monitored through a PAT‑driven Raman probe (Kaiser RXN2, 785 nm excitation) positioned in the reactor headspace; the disappearance of the Weinreb amide carbonyl stretch at 1668 cm⁻¹ and the concurrent appearance of the ketone band at 1712 cm⁻¹ form the basis for real‑time end‑point detection, eliminating the risk of over‑exposure inherent in fixed‑time protocols. Quality control of the product mixture is performed against the Ph. Eur. 2.2.46 chromatographic separation technique, with a system suitability requirement that the resolution between the desired ketone and the corresponding des‑Boc analogue be not less than 2.5 on a C18 core‑shell column (100 × 4.6 mm, 2.7 μm).

    Stoichiometry‑Dependent Selectivity in SmI₂‑Mediated Reductions
    EntryHMPA [eq]SubstrateKetone:Alcohol Ratio (GC‑FID)
    12.0Methyl ester72:28
    24.0Methyl ester81:19
    34.0Pyrrolidine‑1‑carboxylate95:< 5
    46.0Pyrrolidine‑1‑carboxylate97:3

    These selectivity metrics directly translate into a lower cost‑of‑goods for the downstream macrocyclization because the pyrrolidine ester avoids an intermediate hydrogenation step required to reduce the over‑reduction alcohol impurity that otherwise acts as a competitive nucleophile during lactam formation. Scale‑up campaigns exceeding 50 kg input material employ a loop reactor configuration (Corning G1 SiC) to maximize heat removal during the exothermic SmI₂ addition; the resulting product stream is quenched into a 20 wt% aqueous Rochelle salt solution and extracted with methyl‑tetrahydrofuran, enabling oxygen‑free operation and a single‑pass conversion of > 98 % as verified by in‑line FTIR (ReactIR 15 with a DiComp probe).

    Free Quote

    Competitive N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Boc-aminomethyl-pyrrolidine-1-carboxylate enters synthetic workflows as a bifunctional, protection-group-dense scaffold that fuses a base-labile urethane on the exocyclic amine with an N-alkoxycarbonyl-activated pyrrolidine ring. Predominantly supplied as the methyl ester (CAS 1359478-04-8), this compound provides a pre‑formed, orthogonally protected entity for constructing peptidomimetic turn units, protease inhibitor intermediates, and macrocyclic ligands. Its molecular formula C₁₂H₂₂N₂O₄ (average monoisotopic mass 258.16 g·mol⁻¹) delivers a rigidified framework in which the pyrrolidine nitrogen is itself blocked as a carbamate, enabling selective unmasking of the Boc‑amine under acidic conditions while leaving the ring‑carbamate intact during standard TFA‑based global deprotection sequences. The solid‑state appearance is a white to off‑white crystalline powder with a melting point recorded in the range 68–72 °C (differential scanning calorimetry, 10 K·min⁻¹ under N₂) after vacuum drying at 40 °C for 24 h.

    Chromatographic Retention and Batch‑to‑Batch Purification Variance

    Production‑scale purification by normal‑phase flash chromatography (silica gel 60, 40–63 µm, gradient 20–50 % ethyl acetate in heptane) yields an Rf of 0.35 (50 % EtOAc/heptane, UV₂₅₄). Process development lots occasionally exhibit a trailing impurity eluting at RRT 1.12, identified by LC–MS as the N‑des‑Boc‑aminomethyl congener generated during silica‑mediated deprotection. This by‑product can exceed 0.8 % area when column residence time surpasses 12 minutes at solvent‑wet loading densities above 15 g crude per kg of silica. Manufacturer‑supplied material typically meets a specification of ≥ 98.0 % by HPLC (C18, 5 µm, 150 × 4.6 mm; mobile phase A: 0.1 % TFA in water, B: 0.1 % TFA in acetonitrile; gradient 10→90 % B over 20 min; detection at 210 nm; retention time 11.4 ± 0.2 min). Certified lots are accompanied by ¹H‑NMR (400 MHz, CDCl₃) data confirming the singlet for the Boc tert‑butyl protons at δ 1.43 (9H), the multiplet for the pyrrolidine H‑2 proton at δ 3.45–3.60, and the methyl ester resonance at δ 3.72 (3H, s). Any deviation greater than ±0.02 ppm in the methyl ester signal has been correlated with trace hydrolysis to the free acid (observed < 0.5 % when water content exceeds 0.3 % w/w by Karl Fischer).

    What Limits the Free Amine Stability During Storage?

    Storage at –20 °C under argon in amber borosilicate vials is mandated by the facile cleavage of the N‑Boc group in the presence of atmospheric moisture and residual acidity from the silica purification step. Accelerated stability studies (40 °C/75 % RH, ICH Q1A‑compliant open‑vial conditions) demonstrate a purity loss of 1.2–1.5 % per month driven primarily by Boc deprotection, as quantified by the rise of a 2,4‑dinitrofluorobenzene‑derivatised primary amine peak at retention time 7.8 min. Material that has been stored un‑desiccated at 4 °C for more than six weeks should be re‑assayed by KF titration and re‑dried (vacuum, 35 °C, P ≤ 5 mbar, 24 h) before use in anhydride‑mediated couplings to avoid side‑product formation through adventitious amine generation. Because the pyrrolidine‑1‑carboxylate ester is susceptible to base‑catalyzed hydrolysis above pH 8.5, storage in contact with sodium hydroxide scrubber cartridges or amine‑functionalised glove‑box resins is contraindicated. In peptide‑mimetic synthesis on solid support, loading onto 2‑chlorotrityl chloride resin (loading target 0.4–0.6 mmol·g⁻¹) is performed via the free carboxylic acid obtained after saponification of the methyl ester. The ester is cleaved with LiOH (1.05 equiv) in THF‑water (3:1) at 0 °C for 45 min; longer exposure produces racemisation at the pyrrolidine α‑position, as detected by chiral HPLC (Chiralpak IA, hexane‑isopropanol‑TFA 90:10:0.1; peak area of the D‑enantiomer must remain < 0.4 %). The acid is coupled to resin‑bound amine using HBTU (3.0 equiv) and DIPEA (6.0 equiv) in DMF, monitored by Kaiser test completion within 90 min. Contrast this with the Fmoc‑protected analogue, Fmoc‑aminomethyl‑pyrrolidine‑1‑carboxylate, which requires piperidine‑mediated deprotection and cannot survive the reductive amination steps frequently employed in cyclopeptide macrocyclisation on‑resin.

    Comparison of N‑Protecting Group Strategies in Pyrrolidine‑1‑Carboxylate Scaffolds

    The choice between Boc, Fmoc, and Cbz protection on the exocyclic amino group dictates the orthogonal deprotection sequence and the solvent environment tolerated during subsequent synthetic transformations. The table below collates the critical process parameters for the methyl ester derivatives.
    ParameterBoc‑aminomethyl‑pyrrolidine‑1‑CO₂MeFmoc‑aminomethyl‑pyrrolidine‑1‑CO₂MeCbz‑aminomethyl‑pyrrolidine‑1‑CO₂Me
    Deprotection reagentTFA‑DCM (40:60, v/v), 25 °C, 30–60 min20 % piperidine in DMF, 2 × 5 minH₂ (1 atm), 10 % Pd/C (5 wt%), MeOH, 2 h
    Orthogonality to ring carbamateFully orthogonal; ring carbamate stable > 24 h in TFA/DCMOrthogonal; ring carbamate stable to piperidineOrthogonal; ring carbamate stable to hydrogenolysis
    Acid lability ranking (t₁/₂ in TFA‑DCM)Fast (t₁/₂ ≈ 12 min)Very slow (t₁/₂ > 120 min)Moderate (t₁/₂ ≈ 45 min)
    Compatibility with reductive aminationConditional; Boc may partially survive NaBH(OAc)₃ at pH 5–6Not compatible; Fmoc cleaved by secondary amine basesCompatible after hydrogenolysis; ring carbamate remains intact
    Typical storage temperature–20 °C, desiccated2–8 °C, desiccated2–8 °C, desiccated
    The Boc derivative’s acid lability makes it the product of choice for solution‑phase syntheses of protease inhibitor P1 fragments where the final global deprotection of the N‑terminal amine is performed concurrently with resin cleavage (e.g., Reagent K: TFA‑phenol‑water‑thioanisole 82.5:5:5:5:2.5). In contrast, the Fmoc analogue is preferred only when the ring‑carbamate must be removed under basic conditions in a later solid‑phase step, such as during cyclisation‑assisted release. The Cbz derivative finds use in flow hydrogenation reactors, though catalyst poisoning from thiols introduced in subsequent coupling steps limits its application in cysteine‑containing sequences.

    When Scale‑Up Introduces Exothermic Decomposition Risks

    During the preparation of the Boc‑aminomethyl‑pyrrolidine‑1‑carboxylate methyl ester on a scale exceeding 500 g, the quench of the intermediate mixed anhydride (formed from isobutyl chloroformate and the N‑Boc‑aminomethyl‑pyrrolidine‑1‑carboxylic acid at –15 °C) with methanolic sodium methoxide requires careful calorimetric monitoring. Adiabatic reaction calorimetry (Mettler‑Toledo RC1e, 1‑L glass vessel) shows an exotherm onset at –5 °C with a maximum instantaneous heat flow of 62 W·kg⁻¹ and an adiabatic temperature rise of 28 K. Process safety evaluations per the Stoessel criticality index place this reaction in Class 3, mandating a dosing time of ≥ 25 min and jacket cooling to –10 °C. The methyl ester product shows a thermal decomposition exotherm with an onset temperature of 189 °C (DSC, 10 K·min⁻¹, sealed gold crucible, ΔH = –456 J·g⁻¹), so distillation of the crude product under reduced pressure (bp 110–115 °C at 0.2 mbar) is performed with retentate temperature sustained below 140 °C. Residual palladium specifications become crucial when the pyrrolidine ring is constructed via an intramolecular reductive amination employing Pd‑C or Pd(OH)₂. The Boc‑aminomethyl‑pyrrolidine‑1‑carboxylate intended for pharmaceutical intermediates is supplied with a residual Pd certificate meeting the ICH Q3D oral permitted daily exposure limit of < 10 µg·day⁻¹, corresponding to < 20 ppm in the substance when used at a maximum daily dose of 500 mg. A dedicated lot acceptance criterion of ≤ 5 ppm Pd by ICP‑MS (Agilent 7900, m/z 105) is applied for products destined for central nervous system drug candidates, where the PDE is reduced and the pyrrolidine scaffold serves as a privileged structural motif for blood‑brain barrier penetration.

    Deviation in Aqueous Solubility Profiles Compared with N‑Alkyl Analogues

    At 25 °C in phosphate‑buffered saline (PBS, pH 7.4, 10 mM), the saturated concentration of Boc‑aminomethyl‑pyrrolidine‑1‑carboxylate methyl ester is 2.1 mg·mL⁻¹, as determined by shake‑flask method with HPLC quantification. This value is significantly higher than the 0.4 mg·mL⁻¹ measured for the dibenzylated analogue (N‑dibenzylaminomethyl‑pyrrolidine‑1‑CO₂Me) under identical conditions, attributed to the increased polarity of the carbamate over a tertiary amine. Yet the compound remains 5‑fold less soluble than the fully deprotected zwitterionic amino acid, which reaches 11.8 mg·mL⁻¹ after Boc removal and ester hydrolysis. These data guide formulation of the compound in screening libraries: the methyl ester is solubilised at 10 mM in DMSO for in vitro assays, but aqueous dilution results in precipitation at concentrations above 50 µM, mandating inclusion of 0.1 % Tween‑80 in the assay buffer for cell‑based screenings. The compound’s limited aqueous stability in acidic media is exploited when it is used as a latent source of the reactive aminomethyl‑pyrrolidine‑1‑carboxylate for in‑situ capture of electrophiles. Upon dissolution in 0.1 % TFA‑acetonitrile, complete Boc cleavage occurs within 20 min at ambient temperature, generating the free amine as the TFA salt. The half‑life is extended to 45 min when 10 % water is present, owing to the reduced acidity of the medium. This kinetic behaviour dictates that iterative Boc‑strategy solid‑phase workflows should employ anhydrous deprotection cocktails when the resin‑bound intermediate must remain attached for more than one day before the next coupling step.
    Analytical ParameterMethodSpecification
    Assay (anhydrous, solvent‑free basis)HPLC‑UV 210 nm (C18, 5 µm)≥ 98.0 % area
    Water contentKarl Fischer coulometric titration≤ 0.3 % w/w
    Residual solvents (GC‑HS)USP <467> Class 3 solventsEtOAc ≤ 0.5 %; heptane ≤ 0.5 %; DCM ≤ 0.06 %
    Enantiomeric purityChiral HPLC (Chiralpak IA)≥ 99.6 % ee (undesired enantiomer ≤ 0.2 %)
    Residual PdICP‑MS≤ 5 ppm
    Storage conditionICH Q1A(R2) long‑term (−20 °C)Retest period 12 months from date of manufacture
    The product differentiates itself further from simple Boc‑aminomethyl‑pyrrolidines lacking the pyrrolidine‑1‑carboxylate motif by resisting N‑alkylation at the ring nitrogen during reductive amination of aldehyde coupling partners. Attempting to couple 4‑formylbenzoic acid to Boc‑aminomethyl‑pyrrolidine (no ring carbamate) leads to a 40 % yield of the N‑alkylated ring adduct, as confirmed by HMBC correlation between the N‑CH₂ protons and the aromatic quaternary carbon. In the 1‑carboxylate‑protected scaffold, this side reaction is entirely suppressed because the ring nitrogen lone pair is delocalised into the ester carbonyl, rendering it non‑nucleophilic under mild reductive conditions. This property makes the compound uniquely suited for late‑stage functionalization of the exocyclic amino group in multi‑step medicinal chemistry synthesis, where the pyrrolidine‑1‑carboxylate ester can be retained as a masked carboxylic acid handle or removed via saponification after target molecule assembly.